RESEARCH-USE BIOSIMILAR ANTIBODY
Girentuximab
Monoclonal antibody · IgG1
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).
TARGETCA9
YMonoclonal antibody
CATALOGSC-BS-507
CATALOG NUMBERSC-BS-507
MOLECULAR WEIGHTApprox. 144.62 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).
Girentuximab is a recombinant research-use antibody directed against CA9.